Country: সুইডেন
ভাষা: সুইডিশ
সূত্র: Läkemedelsverket (Medical Products Agency)
flutikasonpropionat; salmeterol
Sandoz A/S
R03AK06
fluticasone propionate; salmeterol
50 mikrogram/250 mikrogram/dos
Inhalationspulver, avdelad dos
laktitolmonohydrat Hjälpämne; salmeterol 0,05 mg Aktiv substans; flutikasonpropionat 0,25 mg Aktiv substans
Receptbelagt
Förpacknings: Inhalator, 1 x 60 doser; Inhalator, 10 x 60 doser; Inhalator, 6 x 60 doser; Inhalator, 5 x 60 doser; Inhalator, 4 x 60 doser; Inhalator, 3 x 60 doser; Inhalator, 2 x 60 doser
Avregistrerad
2015-11-19
PACKAGE LEAFLET: INFORMATION FOR THE USER Mesaflu Forspiro, 50 microgram/250 microgram/dose, inhalation powder, predispensed SALMETEROL/FLUTICASONE PROPIONATE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Mesaflu Forspiro is and what it is used for 2. What you need to know before you use Mesaflu Forspiro 3. How to use Mesaflu Forspiro 4. Possible side effects 5. How to store Mesaflu Forspiro 6. Contents of the pack and other information 1. WHAT MESAFLU FORSPIRO IS AND WHAT IT IS USED FOR Mesaflu Forspiro is used to treat: asthma This medicine contains two active substances. Salmeterol: a long-acting substance that widens the airways Fluticasone: a corticosteroid which reduces swelling and inflammation in the lungs 2. WHAT YOU NEED TO KNOW BEFORE YOU USE MESAFLU FORSPIRO DO NOT USE MESAFLU FORSPIRO if you are ALLERGIC to salmeterol, fluticasone or to the other ingredient of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Mesaflu Forspiro if you have: heart disease, including an irregular or fast heartbeat overactive thyroid gland high blood pressure diabetes mellitus (Mesaflu Forspiro may increase your blood sugar) low potassium in your blood tuberculosis (TB) now or in the past or other lung infections Contact your doctor if you experience blurred vision or other visual disturbances. Mesaflu Forspiro prevents the onset of breathlessness and wheezing. Please note that it does not work whe সম্পূর্ণ নথি পড়ুন
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Mesaflu Forspiro, 50 microgram/250 microgram/dose, inhalation powder, pre-dispensed Mesaflu Forspiro, 50 microgram/500 microgram/dose, inhalation powder, predispensed 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each metered dose of Mesaflu Forspiro provides: For 50 microgram/250 microgram/dose, inhalation powder, pre-dispensed: 50 micrograms of salmeterol (as salmeterol xinafoate) and 250 micrograms of fluticasone propionate. Corresponding with a delivered dose of: 45 micrograms of salmeterol (as salmeterol xinafoate) and 233 micrograms of fluticasone propionate Excipient with known effect: lactose monohydrate: 12.20 mg per metered dose Each metered dose of Mesaflu Forspiro provides: For 50 microgram/500 microgram/dose, inhalation powder, predispensed: 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms of fluticasone propionate. Corresponding with a delivered dose of: 45 micrograms of salmeterol (as salmeterol xinafoate) and 465 micrograms of fluticasone propionate Excipient with known effect: lactose monohydrate: 11.95 mg per metered dose For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Inhalation powder, pre-dispensed. White, homogenous powder. The pre-dispensed powder, contained in blister, is delivered by a purple plastic dry-powder inhalation device. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _ASTHMA_ Mesaflu Forspiro is indicated in the regular treatment of asthma where use of a combination product (long-acting β 2 agonist and inhaled corticosteroid) is appropriate: patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting β 2 agonist or patients already adequately controlled on both inhaled corticosteroid and long-acting β 2 agonist. _CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)_ Mesaflu Forspiro is indicated for the symptomatic treatment of patients with COPD, with a FEV 1 <60% predicted normal (pre-bronchodilator) and a history of সম্পূর্ণ নথি পড়ুন